# Mathematical modeling of pharmacokinetics and pharmacodynamics of losartan in relation to CYP2C9 allele variants
Pharmacokinetic [Model](https://uni.sirius-web.org:58443/bioumlweb/#de=data/Collaboration/Babaev_Dmitry_Sirius/Data/PK_2/final_model) that predicts plasma concentration-time curves of losartan and its metabolite E-3174 for patients with the most common alleles of the CYP2C9 gene: _CYP2C9*1_, _CYP2C9*2_, and _CYP2C9*3_.

![Model](https://gitlab.sirius-web.org/DB_gentech2023_sirius/CYP2C9/-/raw/master/Pictures/схема_модели_BioUML_english.png)
___

The time-dependent concentrations of losartan and E-3174 after a single oral dose of 50 mg losartan potassium for three _CYP2C9_ homozygotes predicted by the model are shown below:

![concentration-time curves](https://gitlab.sirius-web.org/DB_gentech2023_sirius/CYP2C9/-/raw/master/Pictures/гомозиготы_with_one_legend_eng.png)

C_p - predicted profile of losartan;<br>
C_m - predicted profile of E-3174;<br>
C_p (exp.) - experimental time-course of losartan;<br>
C_m (exp.) - experimental time-course of E-3174.
___
## Base articles
* [(Karatza and Karalis, 2020)](https://onlinelibrary.wiley.com/doi/10.1111/bcpt.13321) - base model
* [(Yasar et al., 2002)](https://ascpt.onlinelibrary.wiley.com/doi/10.1067/mcp.2002.121216) - experimental data